Clostridium innocuum, an emerging pathogen that induces lipid raft-mediated cytotoxicity

References

• Cherny KE, Muscat EB, Reyna ME, et al. Clostridium innocuum: microbiological and clinical characteristics of a potential emerging pathogen. Anaerobe. 2021;71(102418):1–10. doi: 10.1016/j.anaerobe.2021.102418
   Google Scholar
• Aroca-Ferri M, Suarez-Hormiga L, Bosch-Benitez-Parodi E, et al. Peritonitis by Clostridium innocuum associated to peritoneal dialysiss. Rev Esp Quimioter. 2019;32(2):192–193. doi: 10.1016/j.eimc.2012.01.023
   PubMed Web of Science ®Google Scholar
• Castiglioni B, Gautam A, Citron DM, et al. Clostridium innocuum bacteremia secondary to infected hematoma with gas formation in a kidney transplant recipient. Transpl Infect Dis. 2003;5(4):199–202. doi: 10.1111/j.1399-3062.2003.00037.x
   PubMedGoogle Scholar
• Cutrona AF, Watanakunakorn C, Schaub CR, et al. Clostridium innocuum endocarditis. Clin Infect Dis. 1995;21(5):1306–1307. doi: 10.1093/clinids/21.5.1306
   PubMed Web of Science ®Google Scholar
• Chia JH, Feng Y, Su LH, et al. Clostridium innocuum is a significant vancomycin-resistant pathogen for extraintestinal clostridial infection. Clin Microbiol Infect. 2017;23(8):560–566. doi: 10.1016/j.cmi.2017.02.025
   PubMed Web of Science ®Google Scholar
• Ackermann G, Tang YJ, Jang SS, et al. Isolation of Clostridium innocuum from cases of recurrent diarrhea in patients with prior Clostridium difficile associated diarrhea. Diagn Microbiol Infect Dis. 2001;40(3):103–106. doi: 10.1016/S0732-8893(01)00259-0
   PubMed Web of Science ®Google Scholar
• Le PH, Chiu CT, Yeh PJ, et al. Clostridium innocuum infection in hospitalised patients with inflammatory bowel disease. J Infect. 2022;84(3):337–342. doi: 10.1016/j.jinf.2021.12.031
   PubMed Web of Science ®Google Scholar
• Chen YC, Kuo YC, Chen MC, et al. Case-control study of Clostridium innocuum infection, Taiwan. Emerg Infect Dis. 2022;28(3):599–607. doi: 10.3201/eid2803.204421
   PubMed Web of Science ®Google Scholar
• Janoir C. Virulence factors of Clostridium difficile and their role during infection. Anaerobe. 2016;37:13–24. doi: 10.1016/j.anaerobe.2015.10.009
   PubMed Web of Science ®Google Scholar
• Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev. 2005;18(2):247–263. doi: 10.1128/CMR.18.2.247-263.2005
   PubMed Web of Science ®Google Scholar
• Chia JH, Wu TS, Wu TL, et al. Clostridium innocuum is a vancomycin-resistant pathogen that may cause antibiotic-associated diarrhoea. Clin Microbiol Infect. 2018;24(11):1195–1199. doi: 10.1016/j.cmi.2018.02.015
   PubMed Web of Science ®Google Scholar
• Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278(11):8869–8872. doi: 10.1074/jbc.C200651200
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Fujimoto Y, Lucas PC, et al. A critical role of RICK/RIP2 polyubiquitination in nod-induced NF-kappaB activation. EMBO J. 2008;27(2):373–383. doi: 10.1038/sj.emboj.7601962
   PubMed Web of Science ®Google Scholar
• Simons K, Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest. 2002;110(5):597–603. doi: 10.1172/JCI0216390
   PubMed Web of Science ®Google Scholar
• Rogers TJ, Thorpe CM, Paton AW, et al. Role of lipid rafts and flagellin in invasion of colonic epithelial cells by Shiga-toxigenic Escherichia coli O113: H21. Infect Immun. 2012;80(8):2858–2867. doi: 10.1128/IAI.00336-12
   PubMed Web of Science ®Google Scholar
• Hsu CY, Yeh JY, Chen CY, et al. Helicobacter pylori cholesterol-alpha-glucosyltransferase manipulates cholesterol for bacterial adherence to gastric epithelial cells. Virulence. 2021;12(1):2341–2351. doi: 10.1080/21505594.2021.1969171
   PubMed Web of Science ®Google Scholar
• Chen Y, Huang K, Chen LK, et al. Membrane cholesterol is crucial for Clostridium difficile surface Layer protein binding and triggering inflammasome activation. Front Immunol. 2020;11:1675. doi: 10.3389/fimmu.2020.01675
   PubMed Web of Science ®Google Scholar
• Chen Y, Jin H, Tang X, et al. Cell membrane-anchored anti-HIV single-chain antibodies and bifunctional inhibitors targeting the gp41 fusion protein: new strategies for HIV gene therapy. Emerg Microbes Infect. 2022;11(1):30–49. doi: 10.1080/22221751.2021.2011616
   PubMed Web of Science ®Google Scholar
• CWY H, Martin A, Sepich-Poore GD, et al. Translocation of viable gut microbiota to mesenteric adipose drives formation of creeping fat in humans. Cell. 2020;183(3):666–683 e617. doi: 10.1016/j.cell.2020.09.009
   PubMed Web of Science ®Google Scholar
• Lai CH, Lin TL, Huang MZ, et al. Gut commensal parabacteroides goldsteinii MTS01 alters gut microbiota composition and reduces cholesterol to mitigate Helicobacter pylori-induced pathogenesis. Front Immunol. 2022;13(916848). doi: 10.3389/fimmu.2022.916848
   Google Scholar
• Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307(5710):731–734. doi: 10.1126/science.1104911
   PubMed Web of Science ®Google Scholar
• Caruso R, Warner N, Inohara N, et al. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity. 2014;41(6):898–908. doi: 10.1016/j.immuni.2014.12.010
   PubMed Web of Science ®Google Scholar
• Biswas A, Liu YJ, Hao L, et al. Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc Natl Acad Sci U S A. 2010;107(33):14739–14744. doi: 10.1073/pnas.1003363107
   PubMed Web of Science ®Google Scholar
• Magalhaes JG, Fritz JH, Le Bourhis L, et al. Nod2-dependent Th2 polarization of antigen-specific immunity. J Immunol. 2008;181(11):7925–7935. doi: 10.4049/jimmunol.181.11.7925
   PubMed Web of Science ®Google Scholar
• Kim YG, Shaw MH, Warner N, et al. Cutting edge: Crohn’s disease-associated Nod2 mutation limits production of proinflammatory cytokines to protect the host from Enterococcus faecalis-induced lethality. J Immunol. 2011;187(6):2849–2852. doi: 10.4049/jimmunol.1001854
   PubMed Web of Science ®Google Scholar
• Barnich N, Aguirre JE, Reinecker HC, et al. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor kappa B activation in muramyl dipeptide recognition. J Cell Bio. 2005;170(1):21–26. doi: 10.1083/jcb.200502153
   PubMed Web of Science ®Google Scholar
• Travassos LH, Carneiro LA, Ramjeet M, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2010;11(1):55–62. doi: 10.1038/ni.1823
   PubMed Web of Science ®Google Scholar
• Kabi A, McDonald C. FRMBP2 directs NOD2 to the membrane. Proc Natl Acad Sci U S A. 2012;109(52):21188–21189. doi: 10.1073/pnas.1219395110
   PubMed Web of Science ®Google Scholar
• Lafont F, Tran Van Nhieu G, Hanada K, et al. Initial steps of shigella infection depend on the cholesterol/sphingolipid raft-mediated CD44-IpaB interaction. EMBO J. 2002;21(17):4449–4457. doi: 10.1093/emboj/cdf457
   PubMed Web of Science ®Google Scholar
• Abrami L, Liu S, Cosson P, et al. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J Cell Bio. 2003;160(3):321–328. doi: 10.1083/jcb.200211018
   PubMed Web of Science ®Google Scholar
• Du SY, Wang HJ, Cheng HH, et al. Cholesterol glucosylation by Helicobacter pylori delays internalization and arrests phagosome maturation in macrophages. J Microbiol Immunol Infect. 2016;49(5):636–645. doi: 10.1016/j.jmii.2014.05.011
   PubMedGoogle Scholar
• Schwan C, Nolke T, Kruppke AS, et al. Cholesterol- and sphingolipid-rich microdomains are essential for microtubule-based membrane protrusions induced by Clostridium difficile transferase (CDT). J Biol Chem. 2011;286(33):29356–29365. doi: 10.1074/jbc.M111.261925
   PubMed Web of Science ®Google Scholar
• Reynolds CB, Emerson JE, de la Riva L, et al. The Clostridium difficile cell wall protein CwpV is antigenically variable between strains, but exhibits conserved aggregation-promoting function. PLOS Pathog. 2011;7(4):e1002024. doi: 10.1371/journal.ppat.1002024
   PubMed Web of Science ®Google Scholar
• Cherny KE, Balaji A, Mukherjee J, et al. Identification of Clostridium innocuum hypothetical protein that is cross-reactive with C. difficile anti-toxin antibodies. Anaerobe. 2022;75(102555):102555. doi: 10.1016/j.anaerobe.2022.102555
   PubMedGoogle Scholar
• Gagliardi MC, Iwabuchi K, Lai CH. Editorial: role of lipid rafts in anti-microbial immune response. Front Immunol. 2021;12(654776). doi: 10.3389/fimmu.2021.654776
   Google Scholar
• Boyd AR, Hinojosa CA, Rodriguez PJ, et al. Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumonia. BMC Microbiol. 2012;12(73). doi: 10.1186/1471-2180-12-73
   PubMedGoogle Scholar
• Skerry C, Pinn ML, Bruiners N, et al. Simvastatin increases the in vivo activity of the first-line tuberculosis regimen. J Antimicrob Chemother. 2014;69(9):2453–2457. doi: 10.1093/jac/dku166
   PubMed Web of Science ®Google Scholar
• Liao WC, Huang MZ, Wang ML, et al. Statin decreases Helicobacter pylori burden in macrophages by promoting autophagy. Front Cell Infect Microbiol. 2017;6(203). doi: 10.3389/fcimb.2016.00203
   PubMedGoogle Scholar
• Motzkus-Feagans CA, Pakyz A, Polk R, et al. Statin use and the risk of Clostridium difficile in academic medical centres. Gut. 2012;61(11):1538–1542. doi: 10.1136/gutjnl-2011-301378
   PubMed Web of Science ®Google Scholar
• Gaviola ML, Scribe EC, Leverett HN, et al. Statin effects on incidence, treatment success, and mortality of Clostridium difficile infections. J Pharm Pract. 2020;33(4):497–505. doi: 10.1177/0897190019854956
   PubMed Web of Science ®Google Scholar
• Argamany JR, Lee GC, Duhon BD, et al. A possible association between statin use and improved clostridioides difficile infection mortality in veterans. PLoS One. 2019;14(5):e0217423. doi: 10.1371/journal.pone.0217423
   PubMed Web of Science ®Google Scholar
• Ungaro R, Chang HL, Cote-Daigneault J, et al. Statins associated with decreased risk of New onset inflammatory bowel disease. Am J Gastroenterol. 2016;111(10):1416–1423. doi: 10.1038/ajg.2016.233
   PubMed Web of Science ®Google Scholar
• Dickson I. Creeping fat in Crohn’s disease explained. Nat Rev Gastroenterol Hepatol. 2020;17(12):713. doi: 10.1038/s41575-020-00379-0
   PubMed Web of Science ®Google Scholar
• Chen YC, Le PH, Wang YH, et al. Gut colonization and Antibiotic-associated diarrhea by Clostridium innocuum in children and adults. Clin Infect Dis. 2022;76(2):369–371. doi: 10.1093/cid/ciac696
   Web of Science ®Google Scholar
• Hung YP, Lin HJ, Wu CJ, et al. Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection. Anaerobe. 2014;30:24–26. doi: 10.1016/j.anaerobe.2014.07.009
   PubMed Web of Science ®Google Scholar
• Huang SW, Lin SE, Lee CS, et al. Cytomegalovirus colitis combined with Clostridium innocuum as a cause of lower GI bleeding in a patient with COVID-19. Gastrointest Endosc. 2022;95(2):388–390. doi: 10.1016/j.gie.2021.10.004
   PubMedGoogle Scholar
• Liu Q, Mak JWY, Su Q, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71(3):544–552. doi: 10.1136/gutjnl-2021-325989
   PubMed Web of Science ®Google Scholar
• Skinner AM, Petrella L, Spandoni S, et al. Can Clostridium innocuum masquerade as clostridioides difficile? Clin Infect Dis. 2022;75(7):1268–1269. doi: 10.1093/cid/ciac377
   PubMed Web of Science ®Google Scholar